Literature DB >> 6186823

Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.

B H Robertson, D M Moore, M J Grubman, D G Kleid.   

Abstract

Iodination of intact foot-and-mouth disease virus results in the selective labeling of VP1, substantiating its exposed location on the virion. A comparison of tryptic peptides revealed that a single tyrosine-containing peptide was labeled with iodine on intact or protease-cleaved virus. The labeled peptide from intact and protease-cleaved virus was characterized by molecular weight sizing and sequence analysis. Carboxypeptidase digestion of intact VP1, limited trypsin-cleaved VP1, and VP1 purified from bacterially contaminated tissue cultures yielded carboxyterminal residues of leucine, valine-arginine, and serine-alanine, respectively. The correlation of these findings with previous data on the amino acid sequence derived from nucleotide sequencing of serotypes A12 and O1 of foot-and-mouth disease virus VP1 places the probable exposed antigenic region of VP1 in a serotype-variable region including residues 136 through 144.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186823      PMCID: PMC255125     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Isolation and characterization of trypsin-resistant O1 variants of foot-and-mouth disease virus.

Authors:  S J Barteling; R H Meloen; F Wagenaar; A L Gielkens
Journal:  J Gen Virol       Date:  1979-05       Impact factor: 3.891

2.  Effect of trypsin and chymotrypsin on the polypeptides of large and small plaque variants of foot-and-mouth disease virus: relationship to specific antigenicity and infectivity.

Authors:  D M Moore; K M Cowan
Journal:  J Gen Virol       Date:  1978-12       Impact factor: 3.891

3.  Visualization by chilling of protein bands in polyacrylamide gels containing 8 M urea: preparation and quantitation of foot-and-mouth disease virus capsid proteins.

Authors:  H L Bachrach
Journal:  Anal Biochem       Date:  1981-01-15       Impact factor: 3.365

4.  Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages.

Authors:  H L Bachrach; D O Morgan; D M Moore
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

5.  Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.

Authors:  H L Bachrach; D M Moore; P D McKercher; J Polatnick
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

6.  Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli.

Authors:  H Küpper; W Keller; C Kurz; S Forss; H Schaller; R Franze; K Strohmaier; O Marquardt; V G Zaslavsky; P H Hofschneider
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

7.  Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide.

Authors:  D Cavanagh; D V Sangar; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1977-04       Impact factor: 3.891

8.  Alignment of the peptides derived from acid-catalyzed cleavage of an aspartylprolyl bond in the major internal structural polypeptide of avian retroviruses.

Authors:  A S Bhown; J C Bennett; E Hunter
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

9.  Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.

Authors:  O R Kaaden; K H Adam; K Strohmeier
Journal:  J Gen Virol       Date:  1977-02       Impact factor: 3.891

10.  Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes.

Authors:  J C Boothroyd; P E Highfield; G A Cross; D J Rowlands; P A Lowe; F Brown; T J Harris
Journal:  Nature       Date:  1981-04-30       Impact factor: 49.962

View more
  16 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

Authors:  C Tami; G Kaplan; M E Piccone; E L Palma
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 4.  Development of foot-and-mouth disease virus strain characterisation--a review.

Authors:  R P Kitching; N J Knowles; A R Samuel; A I Donaldson
Journal:  Trop Anim Health Prod       Date:  1989-08       Impact factor: 1.559

5.  Cross-reactions of immunoglobulin M and G antibodies with enterovirus-specific viral structural proteins.

Authors:  F Reigel; F Burkhardt; U Schilt
Journal:  J Hyg (Lond)       Date:  1985-10

6.  Structure of the hepatitis A virion: identification of potential surface-exposed regions.

Authors:  B H Robertson; V K Brown; B P Holloway; B Khanna; E Chan
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

8.  Antigenic variation in Foot and Mouth Disease Virus type Asia 1 isolates circulated during 1993-95 in India.

Authors:  P Tulasiram; M Tyagi; K Srinivas; K Prabhudas; C Natarajan; V Suryanarayana
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

9.  Rapid detection and characterization of foot-and-mouth disease virus by restriction enzyme and nucleotide sequence analysis of PCR products.

Authors:  F Locher; V V Suryanarayana; J D Tratschin
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.

Authors:  Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.